# Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer

> **NCT04814407** · — · RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 900 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Blood-derived DNA methylation detection

## Key facts

- **NCT ID:** NCT04814407
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 900 (ESTIMATED)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04814407

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04814407, "Developing Novel Circulating Epigenetic Biomarkers for Early Detection of Lung Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04814407. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*